COVID-19 information exposure and vaccine hesitancy: The influence of trust in government and vaccine confidence

2021 ◽  
pp. 1-10
Author(s):  
Piper Liping Liu ◽  
Xinshu Zhao ◽  
Bo Wan
Vaccines ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 713
Author(s):  
Cheryl Lin ◽  
Jewel Mullen ◽  
Danielle Smith ◽  
Michaela Kotarba ◽  
Samantha J. Kaplan ◽  
...  

Despite vaccines’ effectiveness in reducing the rate of preventable diseases, vaccine hesitancy has threatened public health and economies worldwide. Healthcare providers’ (HCP) communications and behavior strongly influence patient receptivity and uptake. The goal of this review was to examine HCP vaccine perceptions, knowledge, and reservations and how these attitudes affect their recommendations and vaccination practices. Primary research studies published by 16 September 2020 were searched in PubMed, Web of Science, Embase, CINAHL, and PsycINFO. A 14-item scale was developed for survey study and risk of bias appraisal (SSRBA). In total, 96 papers from 34 countries were included, covering 17 vaccines (HPV and influenza vaccines the most studied). Recommendation was positively associated with provider knowledge and experience, beliefs about disease risk, and perceptions of vaccine safety, necessity, and efficacy. HCP vaccination attitudes and practices varied across specialties, vaccines, and countries; demographic impact was inconclusive. Barriers included anticipation of patient/parental concerns or refusal, lacking clear guidelines, time constraints, and cost. For HPV, vaccines were more often recommended to older, female adolescents and by physicians who discussed sexual health. HCPs are vital advocates for patients and the public, but studies indicated a prevalence of provider hesitancy pertaining to inadequate knowledge, low vaccine confidence, and suboptimal uptake themselves. Improving HCP knowledge and assuring their access to information they deem trustworthy are essential to supporting HCPs‘ role as “trusted messengers” to promote vaccine acceptance.


2020 ◽  
pp. 089011712097991
Author(s):  
Sandra Crouse Quinn ◽  
Yuki Lama ◽  
Amelia Jamison ◽  
Vicki Freimuth ◽  
Veeraj Shah

Purpose: Explore acceptability of vaccines in development: cancer, Type II diabetes, Alzheimer’s disease, Lyme disease, Ebola, and obesity. Research questions: To what extent does acceptability vary by vaccine type? To what extent does acceptability of vaccines in development vary by race and other key demographics? To what extent are general vaccine hesitancy and key demographics associated with acceptability of vaccines in development? Design: Cross-sectional online survey administered through GfK’s KnowledgePanel in 2015. Analysis completed in 2020. Subjects: Nationally representative sample of Black and White American adults (n = 1,643). Measures: Willingness to accept a novel vaccine was measured on a 4-point Likert scale. Independent variables included demographics (e.g. age, race, gender) and measures of vaccine hesitancy, trust, and the “Three C’s” of vaccine confidence, complacency, and convenience. Analysis: Exploratory analysis including descriptive statistics and regression modeling. Results: Acceptability varied from 77% for a cancer vaccine to 55% for an obesity vaccine. White race, male gender, older age, having a chronic health condition, and higher socioeconomic status were associated with higher acceptability. Higher vaccine confidence and lower vaccine hesitancy were predictors for acceptability. Conclusion: The success of a vaccine depends on widespread public acceptance. Vaccine hesitancy may hinder acceptance of future vaccines, with significant differences by demographics. Future social science research is necessary to better understand and address vaccine hesitancy.


2022 ◽  
Vol 2 (1) ◽  
pp. e0000165
Author(s):  
Arianna Maever L. Amit ◽  
Veincent Christian F. Pepito ◽  
Lourdes Sumpaico-Tanchanco ◽  
Manuel M. Dayrit

Effective and safe COVID-19 vaccines have been developed at a rapid and unprecedented pace to control the spread of the virus, and prevent hospitalisations and deaths. However, COVID-19 vaccine uptake is challenged by vaccine hesitancy and anti-vaccination sentiments, a global shortage of vaccine supply, and inequitable vaccine distribution especially among low- and middle-income countries including the Philippines. In this paper, we explored vaccination narratives and challenges experienced and observed by Filipinos during the early vaccination period. We interviewed 35 individuals from a subsample of 1,599 survey respondents 18 years and older in the Philippines. The interviews were conducted in Filipino, Cebuano, and/or English via online platforms such as Zoom or via phone call. All interviews were recorded, transcribed verbatim, translated, and analysed using inductive content analysis. To highlight the complex reasons for delaying and/or refusing COVID-19 vaccines, we embedded our findings within the social ecological model. Our analysis showed that individual perceptions play a major role in the decision to vaccinate. Such perceptions are shaped by exposure to (mis)information amplified by the media, the community, and the health system. Social networks may either positively or negatively impact vaccination uptake, depending on their views on vaccines. Political issues contribute to vaccine brand hesitancy, resulting in vaccination delays and refusals. Perceptions about the inefficiency and inflexibility of the system also create additional barriers to the vaccine rollout in the country, especially among vulnerable and marginalised groups. Recognising and addressing concerns at all levels are needed to improve COVID-19 vaccination uptake and reach. Strengthening health literacy is a critical tool to combat misinformation that undermines vaccine confidence. Vaccination systems must also consider the needs of marginalised and vulnerable groups to ensure their access to vaccines. In all these efforts to improve vaccine uptake, governments will need to engage with communities to ‘co-create’ solutions.


Author(s):  
Chiara Cadeddu ◽  
Carolina Castagna ◽  
Martina Sapienza ◽  
Teresa Eleonora Lanza ◽  
Rosaria Messina ◽  
...  

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
H Larson ◽  
A de Figueiredo ◽  
E Karafllakis ◽  
M Rawal

Abstract Background High confidence in vaccination programmes is crucial for maintaining high coverage rates. Across the European Union (EU), however, vaccine delays and refusals are contributing to declining immunisation rates in a number of countries and are leading to increases in disease outbreaks. Methods We assessed the overall state of confidence in vaccines among the public in all 28 EU member states and among general practitioners (GP) in ten EU member states, conducting the largest ever study on attitudes to vaccines and vaccination in the EU, eliciting the views of approximately 28,000 respondents across the 28 EU member states. Results We found that a number of member states (including France, Greece, Italy, and Slovenia) have become more confident in the safety of vaccines since 2015, but that the Czech Republic, Finland, Poland, and Sweden have become less confident. While GPs generally hold higher levels of vaccine confidence than the public, the survey found that 36% of GPs surveyed in Czech Republic and 25% in Slovakia do not agree that the MMR vaccine is safe and 29% and 19% respectively do not believe it is important. Countries whose GPs hold higher confidence in vaccines tend to have a larger proportion of the public expressing positive vaccination beliefs. Conclusions Even countries with well-established vaccination programmes and high levels of confidence are not immune to rising vaccine hesitancy. There is a need for continuous monitoring, preparedness and response plans to maintain and increase confidence in the importance, effectiveness and safety of vaccines, among both the public and health professionals.


2019 ◽  
Vol 37 (3) ◽  
pp. 245-267
Author(s):  
Francesca Camilleri

Vaccination for children has been a controversial topic for decades and lately it has regained particular importance. We have seen an increase in vaccine hesitancy and decrease in vaccine confidence throughout Europe, particularly due to vaccine-safety concerns by parents. Consequently, vaccination rates for children have dropped and this in turn has led to an increased spread of vaccine-preventable infectious diseases, such as measles. As a reaction to this phenomenon of vaccine hesitancy, several European countries have introduced, while others are in the process of introducing, laws making vaccinations compulsory for children for a number of vaccine-preventable childhood diseases. The introduction of such laws affects and gives rise to several competing interests of the parents, the child and the State. Against this background, this article seeks to determine how the European Court of Human Rights should balance the competing human rights that are at stake in cases concerning compulsory vaccinations for children.


2021 ◽  
Vol 17 (3) ◽  
Author(s):  
Kate C. Prickett ◽  
Simon Chapple

The long-term success of New Zealand’s Covid-19 elimination plan and the re-opening of fortress New Zealand rests on high population uptake of the Covid-19 vaccine. Understanding factors that contribute to vaccine hesitancy – and potential inequities in access and uptake – are consequently essential for the efficacy of the national immunisation programme which began rolling out to the general population in July 2021. Prior research on the New Zealand context has documented socio-demographic disparities in Covid-19 vaccine hesitancy (Horizon Research, 2020; Prickett, Habibi and Atatoa Carr, 2021; Thaker, 2021). However, little research has been undertaken to examine how psychosocial elements – such as people’s trust in institutions – might be associated with people’s vaccine intent and cast some light on the reasons underpinning their intent.


2021 ◽  
Author(s):  
Mouhamadou Faly Ba ◽  
Adama Faye ◽  
Babacar Kane ◽  
Amadou Ibra Diallo ◽  
Amandine Junot ◽  
...  

Introduction: The most effective way to control the COVID-19 pandemic in the long term is through vaccination. Two of the important components that can hinder it are vaccine hesitancy and vaccine refusal. This study, conducted before the arrival of the vaccines in Senegal, aims to assess and identify factors associated with hesitancy to the COVID-19 vaccine. Methods: This study was an explanatory, sequential, mixed-methods design. We collected quantitative data from December 24, 2020, to January 16, 2021, and qualitative data from February 19 to March 30, 2021. We conducted a marginal quota sampling nationwide. We used a structured questionnaire to collect data for the quantitative phase and an interview guide with a telephone interview for the qualitative phase. We performed descriptive, bivariate, and multivariate analyses with R software version 4.0.5 for the quantitative phase; and performed manual content analyses for the qualitative phase. Results: We surveyed 607 people for the quantitative phase, and interviewed 30 people for the qualitative phase. Individuals who hesitated or refused to be vaccinated represented 12.9% and 32.8%, respectively. Vaccine hesitancy was related to gender, living in large cities, having a poor attitude towards the vaccine, thinking that the vaccine would not help protect them from the virus, being influenced by people important to them, and lacking information from health professionals. Vaccine refusal was related to living in large cities, having a poor attitude towards the vaccine, thinking that the vaccine would not help protect them from the virus, thinking that the vaccine could endanger their health, trusting opinions of people who were important to them, and lacking information from health professionals. Conclusion: The results of the study show that the factors associated with hesitancy and refusal to be vaccinated against COVID-19 are diverse and complex. Reducing them will help to ensure better vaccination coverage if the current challenges of vaccine accessibility are addressed. Therefore, governments and health authorities should intensify their efforts to promote vaccine confidence and reduce misinformation. Keywords: Vaccine hesitancy, COVID-19, Mixed method, Senegal


Author(s):  
Manoja Kumar Das ◽  
Deepak Singh

Background: The media news influence shapes the public sentiments and behaviour. The recent experiences indicate significant influence of online news and social media on immunization behaviour in India. The objective was to study the profile and sentiments of online media news on vaccine and vaccination in India.Methods: We searched the online news published during November 2015 to October 2017. The news contents were interpreted and categorised according to the vaccine and sentiments.Results: Out of the total 1430 news items, 763 were eligible for review after removal of duplicates and unrelated items. Majority (75.5%) of the news were on the immunization program. While 45.5% news originated from sub-state level, 19.3% from state and 35.2% were from national levels. The measles-rubella vaccine topped the news (23.5%) followed by poliomyelitis (10.4%) and Japanese encephalitis (6.6%) vaccines. While 65.8% of news was positive, 27.9% and 6.35% were negative and neutral respectively. The negative news comprised of the adverse events, social resistance, and vaccine shortageent.Conclusions: A sizable proportion of news contained negative messages, which may influence public vaccine behaviour. Past experiences (pentavalent and measles-rubella) calls for regular monitoring of media messages and adopt appropriate communication strategy to retain vaccine confidence and reduce vaccine hesitancy.


Sign in / Sign up

Export Citation Format

Share Document